Matthew Readings

Shearman & Sterling (London)
Lawyer (Partner)

Mr. Readings is co-head of the Global Antitrust Group and the managing partner of the firm’s Brussels office. He splits his time between Brussels and London with a practice focused on EU and UK competition law, including transactional and behavioural/contentious work. Mr. Readings advises clients on cartel investigations by the European Commission and appeals to the European Courts (where he appears as an advocate). He advises in respect of UK cartel investigations and market studies / investigations by the CMA and sector regulators such as the FCA. He is experienced in private enforcement of antitrust rights in the UK courts. Mr Readings advises a broad range of clients on strategic merger clearance issues, representing clients before the European Commission and the CMA. He oversees multi-jurisdictional merger clearance processes in countries throughout the world. He has advised on complex European Commission and CMA cases including Phase II investigations and remedy cases. Mr. Readings qualified as a solicitor in 1996 at Lovells and remained there until 2006, becoming a partner in 2004. Whilst at Lovells, he spent time on secondment to Lazard. He joined Shearman & Sterling as a partner in February 2006. Mr. Readings is recommended in the principal legal directories, including for example Chambers, and teaches EU competition law at Oxford University.

Distinctions

Linked authors

French General Inspectorate of Finance (Paris)
Arnold & Porter Kaye Scholer (Brussels)
Georgetown University (Washington D.C.)
European Commission (Brussels)
George Mason University (Fairfax)
United Kingdom’s Competition Authority - CMA (London)
French State Council (Paris)
ESSEC Business School (Cergy)

Articles

3345 Bulletin

Matthew Readings, James Webber, Sara Ashall The UK Competition Authority publishes a series of regulatory initiatives aimed at online platforms focussed on digital advertising and signals a new path for UK clampdown on big techs due to the current inadequate competition law toolkit

277

On 1 July 2020, the U.K. Competition and Markets Authority (CMA) published a statement outlining a series of regulatory initiatives aimed at Google and Facebook, focussed on digital advertising. This follows the release of the CMA’s report on digital advertising and online platforms the same (...)

James Webber, Ruba Noorali, Sara Ashall, Matthew Readings, Elvira Aliende Rodriguez The EU Commission announces a major relaxation of the State aid rules via a new Temporary Framework during the COVID-19 outbreak

187

How will European Competition Enforcers Respond? The COVID-19 pandemic presents an unprecedented challenge to the economy and competition enforcement is no exception. Authorities at EU and national level may need to consider novel solutions to respond to rapidly evolving problems and to (...)

Elvira Aliende Rodriguez, Ruba Noorali, Matthew Readings The EU General Court reaffirms the Commission’s duty to provide sufficient reasons when explaining fine calculations in cartel cases (HSBC)

446

On 24 September 2019, the EU General Court (GC) handed down its judgment in HSBC v. Commission. Consistent with recent precedent, the GC reaffirmed the European Commission (“Commission”)’s duty to provide sufficient reasons when explaining fine calculations in cartel cases and annulled the fine (...)

Sara Ashall, James Webber, Matthew Readings The EU Commission imposes a fine of €28 million for “gun-jumping” on a Japanese manufacturer of imaging and optical products (Canon / Toshiba)

1134

On 27 June 2019 the European Commission imposed a fine of €28 million on the Japanese imaging and optical products manufacturer Canon for “gun-jumping” by using a warehousing structure in its 2016 acquisition of Toshiba Medical Systems (TMS), and this comes two years after the Commission announced (...)

Geert Goeteyn, James Webber, Matthew Readings, Ruba Noorali The EU Commission considers potential harm to innovation as part of its merger assessments, particularly in R&D driven sectors such as pharmaceuticals and technology (Bayer / Monsanto)

815

The European Commission has routinely considered potential harm to innovation as part of its merger assessments, particularly in R&D driven sectors such as pharmaceuticals and technology. In recent years, however, the Commission’s traditional innovation concerns have developed into broader, (...)

Geert Goeteyn, James Webber, Matthew Readings The EU Commission sends a statement of objections to a company to investigate whether a merger was implemented prior to the Commission’s clearance (Alice / PT Portugal)

486

When a transaction meets the thresholds of the EU Merger Regulation, companies must notify and obtain clearance from the European Commission before implementing the transaction. This means that until clearance is obtained, companies should continue to operate independently (including (...)

427 Review

Alexander Italianer, Anne Perrot, Howard Shelanski, Matthew Readings Restructuring firms in the context of crisis: What role for merger policy? (New Frontiers of Antitrust, Paris, 21 February 2014)

427

This last roundtable of the conference “New frontiers of Antitrust” (Paris, 21 February 2014) was dedicated to the “Restructuring firms in the context of crisis: What role for merger policy?». The objective of this roundtable is to explore in what respect the various issues involved in merger (...)

Send a message